Skip to main content
  • Business
      |Business
    • Business Intelligence
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Management
    • Mergers & Acquisitions
    • Policy & Regulations
    • Professional Associations
    • Staffing
    • Supply Chain
  • Care
      |Care
    • Care Delivery
    • Covid-19
    • Digital Transformation
    • Telehealth
  • Data
      |Data
    • Artificial Intelligence
    • Cybersecurity
    • EMR/EHR
    • Informatics
  • Videos
  • Conferences
      |Conferences
    • AHA
    • AMA
    • CHIME
    • HFMA
    • HIMSS
    • MGMA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home

J&J splits | Consolidation in the advisory subsector | Home tests recalled

News You Need to Know Today
J&J splits | Consolidation in the advisory subsector | Home tests recalled
Tuesday, November 16, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Kaufman Hall acquires Healthcare Real Estate Capital

Kaufman, Hall & Associates has acquired Healthcare Real Estate Capital, a national advisory firm focused on the healthcare and higher education real estate capital markets sectors.

 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Kaufman Hall acquires Healthcare Real Estate Capital

Share on Twitter Share on Facebook Share on Linkedin
Kaufman, Hall & Associates has acquired Healthcare Real Estate Capital, a national advisory firm focused on the healthcare and higher education real estate capital markets sectors.  
READ MORE >

130-year-old Johnson & Johnson will split into two public companies

J&J's consumer business—responsible for Tylenol, Band-Aid and more household names—will separate from its pharmaceutical and medical device division.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

130-year-old Johnson & Johnson will split into two public companies

Share on Twitter Share on Facebook Share on Linkedin
J&J's consumer business—responsible for Tylenol, Band-Aid and more household names—will separate from its pharmaceutical and medical device division.
READ MORE >

Featured Articles

Biden expected to choose cardiologist who served under Obama as next FDA commissioner

Robert Califf, MD, is a practicing cardiologist and professor of cardiology at the Duke University School of Medicine. 

READ MORE >
 U.S. Senate has confirmed cardiologist Robert Califf as next FDA commissioner. 
Share on Twitter Share on Facebook Share on Linkedin

Biden expected to choose cardiologist who served under Obama as next FDA commissioner

Share on Twitter Share on Facebook Share on Linkedin
 U.S. Senate has confirmed cardiologist Robert Califf as next FDA commissioner. 
Robert Califf, MD, is a practicing cardiologist and professor of cardiology at the Duke University School of Medicine. 
READ MORE >

FDA recalls 2.2M at-home COVID tests due to false positive results

Ellume was the first company to gain federal authorization for an over-the-counter test to detect COVID-19.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA recalls 2.2M at-home COVID tests due to false positive results

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
Ellume was the first company to gain federal authorization for an over-the-counter test to detect COVID-19.
READ MORE >

In Case You Missed It

Pandemic effects: Insurance premiums up 4%

Health insurance premiums have risen 4% for workers in 2021.

 

READ MORE >
patient image portal sharing covid-19
Share on Twitter Share on Facebook Share on Linkedin

Pandemic effects: Insurance premiums up 4%

Share on Twitter Share on Facebook Share on Linkedin
patient image portal sharing covid-19
Health insurance premiums have risen 4% for workers in 2021.  
READ MORE >

1 in 3 defer healthcare due to cost

Far too many patients are deferring healthcare services due to outstanding medical bills.

 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

1 in 3 defer healthcare due to cost

Share on Twitter Share on Facebook Share on Linkedin
Far too many patients are deferring healthcare services due to outstanding medical bills.  
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

UHC accused of $100M Medicaid fraud scheme | Healthcare AI roundup | Black physician directory sued | AMGA interview
Economics: PE hospital now a nonprofit | Reducing prior authorizations by 30% | Practice consolidation | GLP-1 price spike
Weekly Update: CVS sues over PBM laws | Black matter in IV spurs FDA alert | Ebola response | Hospital network buys CHCP
Primary care as a utility | CDC seeking volunteers to contain Ebola | Walmart partners with Teladoc | Ambient AI lawsuits
FDA issues black matter alert | Social worker violence | HCA buys healthcare college | Advanced access advantages
CVS sues Tennessee as PBM bill becomes law | Ōura Ring files paperwork to go public | Healthcare fraud busting | more
CVS faces $250M lawsuit | Connecticut Medicaid hacked | PE hospital chain switches to nonprofit | Licensing clinical AI

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme